Will be interesting to see what IPIX decides to do

Quote:

---

Will be interesting to see what IPIX decides to do with the Brilacidin industrial business that will arise from the polymer derivative that can be introduced into textiles, plastics, and paints to make these products sterilized and non microbial.

---

I know there is talk about formulations for medical device coatings. I envisioned this as an antimicrobial/anti inflammatory gel or liquid of sorts applied to the device (anything in or attached to the body - rods, pacemakers, meshes, etc.) rather than a permanent and static coating. I guess I missed the polymer announcement.

I would question the wisdom of putting critical antimicrobial compounds in a form that gives widespread and constant exposure. As anyone who has seen Jurassic Park knows, given enough time, life always finds a way. The panacea of healing that Brilacidin may end up being needs to be reserved for where it is needed most. ABSSSI, OM, HS and other severe diseases are what it should be used for. I cringe when I think of it being used for anything but the most severe acne as the potency off the compound needs to be preserved. Brilacidin is resistance resistant, not resistance proof.

To answer your question, I believe this will be decided by whatever entity ends up buying us out. I believe we will be pitched an offer we cannot refuse for the whole enchilada long before we ever consider much beyond medical devices. That number will depend on how our outstanding phase 2 trials end up. Cash is very cheap right now and pipelines are very thin at over a dozen $50B+ pharma companies.

That said, I admire your vision toward the future. Many technological breakthroughs are derived at companies that started off on an unrelated path.

Either way, as always, Go IPIX!

All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.